An objection to this test was that there was difference between the rate of infections among patients with biliary pancreatitis 12% and the rate of infections among patients with alcoholic etiology 9% which resulted in a greater number of patients with biliary pancreatitis in the meropenem group.
Una objeción de este ensayo fue la diferencia entre la tasa de infecciones en la pancreatitis biliar 12% comparada con la de etiología alcohólica 9% con un mayor número de pancreatitis biliares en el grupo de meropenem.